Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAGENICS LIMITED Director's Dealing 2018

Sep 12, 2018

64383_rns_2018-09-12_d7561e5d-0321-49d2-baeb-a8f7d03aedc5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Cellmid Limited
ABN 69 111 304 119

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr Bruce Gordon
Date of last notice 17 October 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or ind irect interest Indirect
Nature of in direct interest P A D P ty Limited <Gordon Superann uation
(including rNote: Provide d gistered holder)etails of the circumstances giving rise to the rele vant Fund>
interest.
Date of chan ge 12 Septem ber 2018
No. of secur ities held prior to change 75,000 ful ly paid ordinary shares 1/2018
100,000 u nlisted options @ $1.20 ex 19/1
Class Fully paid ordinary shares
Number acquired 26,316
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $0.38 per share (total value of $10,000)
No. of securities held after change Indirect101,316 fully paid ordinary shares100,000 unlisted options @ $1.20 ex 19/11/2018
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Participation in the Share Purchase Plan pursuant to the Share Purchase Plan booklet lodged with ASX on 31 July 2018.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
Date of change N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade N/A to proceed during this period? If prior written clearance was provided, on what date was this N/A provided?

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011